Company Overview

    Swiss Medica is a specialty pharmaceutical company focused on commercializing over-the-counter clinically-
    tested, patented all-natural products that relieve chronic ailments. Swiss Medica builds its brands through
    innovative and focused distribution and marketing strategies. Swiss Medica's mission is to be a world leader in
    the commercialization of over-the-counter, safe and effective chronic ailment treatments.

    Swiss Medica's flagship product, the O24™ Pain Neutralizer, holds US Patent #6,444,238B1. The O24™ pain
    relief solution has been used and recommended for its fast-acting and long-lasting benefits by healthcare
    professionals and athletes in the United States, Canada and in Europe. O24™ is widely available over-the-
    counter throughout the United States and Canada in leading pharmacies and other retailers.

    Swiss Medica has recently launched the patented O24 Fibromyalgia™ pain reliever (US Patent #6,444,238B1)
    over-the-counter in North American retailers. The National Fibromyalgia Association (NFA) recently awarded
    O24 Fibromyalgia™ their first NFA Seal of Approval. Over 10 million Americans suffer from the long-term pain
    associated with fibromyalgia. In a randomized double blind clinical trial conducted in 2005, 88 percent of the
    patients who used O24 Fibromyalgia™ reported mild to markedly better improvement, versus only 7 percent who
    used the placebo.